Trump administration reclassifies medical marijuana as a 'less-dangerous drug'
Summary
President Donald Trump’s administration has officially reclassified state-licensed medical marijuana from a Schedule I drug to a less-restrictive Schedule III drug. This change makes it easier to research medical marijuana and gives state-licensed cannabis businesses new tax benefits, but it does not legalize marijuana federally.Key Facts
- Medical marijuana moved from Schedule I (most restricted) to Schedule III (less restricted) under federal rules.
- Schedule I drugs are considered to have no medical use and a high potential for abuse, while Schedule III drugs are recognized for medical use with lower abuse risk.
- The reclassification helps researchers get access to state-licensed cannabis for scientific studies without penalty.
- Licensed medical marijuana businesses can now deduct business expenses on federal taxes.
- The Justice Department will hold a hearing in late June to consider broader reclassification of marijuana.
- President Trump directed his administration to quickly reclassify marijuana back in December 2025.
- This change affects medical marijuana programs in 40 states that have legalized it.
- Recreational marijuana remains illegal under federal law despite some states allowing it.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.